[ORGANIZATION]
CHMP
Featured in 2 tracked stories · first seen
Situations
AIFA pharmaceutical innovation and evaluation discussions
2 clusters · 10 sources · last updated
Latest: AIFA President Nisticò discusses pharmaceutical innovation and drug authorization
The Italian Medicines Agency (AIFA) has initiated institutional dialogues focused on the value of pharmaceutical innovation and its impact on the Italian National Health Service. During a conference in Genoa, discussions
EMA CHMP and EU Commission medicinal product approvals
3 clusters · 24 sources · last updated
Latest: European Commission approves Ocrevus for pediatric multiple sclerosis
In September 2026, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of 12 new medicines and therapeutic extensions for 11 existing ones. Among the